CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.
Saved in:
| Title: | CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma. |
|---|---|
| Authors: | Moser LM; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany., Heim C; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany., Koschade SE; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany., Wendel P; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany., Bozkurt S; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany., Harenkamp S; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany., Kreyenberg H; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany., Merker M; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany., Münch C; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.; Cardio-Pulmonary Institute, Frankfurt am Main, Germany., Gradhand E; Department of Pediatric and Perinatal Pathology, Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Vogler M; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute for Experimental Pediatric Hematology and Oncology, Goethe University, Frankfurt am Main, Germany., Ullrich E; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany., Bönig H; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, United States., Klusmann JH; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany., Bader P; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany., Wels WS; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany., Rettinger E; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Feb 03; Vol. 16, pp. 1485817. Date of Electronic Publication: 2025 Feb 03 (Print Publication: 2025). |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39963129 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Moser+LM%22">Moser LM</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Heim+C%22">Heim C</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Koschade+SE%22">Koschade SE</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wendel+P%22">Wendel P</searchLink>; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Bozkurt+S%22">Bozkurt S</searchLink>; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Harenkamp+S%22">Harenkamp S</searchLink>; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Kreyenberg+H%22">Kreyenberg H</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Merker+M%22">Merker M</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Münch+C%22">Münch C</searchLink>; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.; Cardio-Pulmonary Institute, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Gradhand+E%22">Gradhand E</searchLink>; Department of Pediatric and Perinatal Pathology, Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Vogler+M%22">Vogler M</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute for Experimental Pediatric Hematology and Oncology, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Ullrich+E%22">Ullrich E</searchLink>; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Bönig+H%22">Bönig H</searchLink>; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Klusmann+JH%22">Klusmann JH</searchLink>; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Bader+P%22">Bader P</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wels+WS%22">Wels WS</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Rettinger+E%22">Rettinger E</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Feb 03; Vol. 16, pp. 1485817. <i>Date of Electronic Publication: </i>2025 Feb 03 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39963129 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1485817 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1485817 Titles: – TitleFull: CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Moser LM – PersonEntity: Name: NameFull: Heim C – PersonEntity: Name: NameFull: Koschade SE – PersonEntity: Name: NameFull: Wendel P – PersonEntity: Name: NameFull: Bozkurt S – PersonEntity: Name: NameFull: Harenkamp S – PersonEntity: Name: NameFull: Kreyenberg H – PersonEntity: Name: NameFull: Merker M – PersonEntity: Name: NameFull: Münch C – PersonEntity: Name: NameFull: Gradhand E – PersonEntity: Name: NameFull: Vogler M – PersonEntity: Name: NameFull: Ullrich E – PersonEntity: Name: NameFull: Bönig H – PersonEntity: Name: NameFull: Klusmann JH – PersonEntity: Name: NameFull: Bader P – PersonEntity: Name: NameFull: Wels WS – PersonEntity: Name: NameFull: Rettinger E IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 02 Text: 2025 Feb 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |